LGC Mikromol™

Nitrosamine impurities continue to be one of the biggest compliance challenges in the pharmaceutical industry. Our new whitepaper explains why nitrosamines form, how to control them, and what structural risks to watch for - giving you a practical framework for assessing and mitigating nitrosamine risk. 👉Get your copy here: https://ow.ly/ftql50XatbY. #Nitrosamines #NDSRIs #PharmaceuticalDevelopment #DrugSafety #RegulatoryCompliance

More than half of our recent webinar attendees agreed:👉 Method sensitivity is the biggest challenge in nitrosamine risk assessment. If you’re facing the same issue, you’re not alone - and there are proven ways to overcome it. 🎥 Watch our on-demand webinar, Mastering Trace-Level Nitrosamine Detection: Pitfalls & Proven Solutions, to explore real-world case studies and practical strategies for more accurate, reliable analysis. https://ow.ly/hjzu50XaA7e #Webinar #NDSRIs #NitrosamineAnalysis #pharma

The wide range of nitrosamine contaminants poses a major challenge for quality scientists developing sensitive, reliable detection methods. ▶️In this on-demand webinar, we outline the process for building a new analytical method — from analytical setup through to validation — illustrated with the example analyte N-nitroso-sertraline. Watch the webinar here: https://ow.ly/P8pk50X6n9z #Webinar #NDSRIs #NitrosamineAnalysis #pharma

🧠💊 #PharmaQuiz Ropinirole is a prescription medicine used to manage Parkinson’s disease and restless legs syndrome. It’s been an important tool for improving motor control and quality of life. But one of its side effects has caught clinicians’ attention… 💭Which surprising side effect has been linked to ropinirole? Drop your guess in the comments ⬇️ We'll reveal the answer next week!

Looking to expand your inventory or stock up on trusted compounds? Explore over 2,500 high-quality Toronto Research Chemicals products - now available at up to 80% off! Our discounted portfolio supports the full pharmaceutical lifecycle, including: ✔ Impurities ✔ Metabolites ✔ APIs ✔ Stable isotope-labelled compounds View the new flyer: https://ow.ly/4bXn50X4PWZ #PharmaResearch #DrugDiscovery #ImpurityAnalysis #ReferenceStandards

👇This diagram highlights the key factors driving nitrosamine formation, alongside practical strategies to mitigate them. For more details, download our latest whitepaper, "Nitrosamine formation in pharmaceuticals – pathways and prevention strategies" https://ow.ly/3A1U50X2VWA #Nitrosamines #NDSRIs #PharmaceuticalDevelopment #DrugSafety #RegulatoryCompliance

Missed our live webinar “Mastering Trace-Level Nitrosamine Detection: Pitfalls & Proven Solutions”? You can now watch it on demand! ▶️https://ow.ly/Rsej50X0cFf This session dives into real-world case studies showing how to overcome common pitfalls in nitrosamine analysis: 1) N-nitroso-sertraline – In partnership with Waters Corporation, we developed a sensitive UPLC–MS/MS method, addressing pitfalls like in-sample nitrosation. 2) Rifampin and rifapentine – How matrix effects masked an out-of-spec result, and how stable isotope-labelled standards, LC optimisation, and standard addition resolved it. Don’t miss this chance to hear from experts and take away proven solutions for your lab. #Webinar #NDSRIs #NitrosamineAnalysis #pharma

From biomarkers to organ-on-a-chip models, new tools are transforming how we predict toxicity and drug–drug interaction (DDI). Download the full white paper for practical guidance aligned with ICH M12: https://ow.ly/aKcR50X07P5 #DrugDevelopment #DDI #PBPK #ICHM12

We’re heading to QC Pharma Day 2025 in Milan next month! Meet our team — Simone Colombo, Luigi Barbarossa, and Claudia Sala — and discover how our pharmaceutical reference materials can help your lab achieve accuracy, compliance, and confidence in quality control. Whether you’re working in API development, finished product testing, or impurity analysis, our experts are here to connect and explore solutions tailored to your analytical challenges. 🔗 Explore our pharma portfolio here: https://ow.ly/gAGV50WWFqh Looking forward to connecting in Milan! #QCPharmaDay #ReferenceMaterials #ScienceForaSaferWorld

🌍Regulators worldwide are tightening requirements on nitrosamine impurities in medicines, reflecting growing concern about their potential carcinogenicity. From August 2025, the FDA’s temporary 5 ppm limit has been replaced by compound-specific acceptable intake thresholds. How prepared is your team for this regulatory shift? 👇 Vote and see how others are approaching compliance.